0
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Expression of the vascular endothelial growth factors B and C and their receptors in human endometrium during the menstrual cycle

, &
Pages 817-824 | Published online: 07 Aug 2009

References

  • Larrivee B, Karsan A. Signaling pathways induced by vascular endothelial growth factor (review). Int J Mol Med 2000; 5: 447–56.
  • Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996; 226: 324–8.
  • Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pajusola K et al. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 1998; 282: 946–9.
  • Ferrara N. Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol 1999; 237: 1–30.
  • Krüssel JS, Casan EM, Raga F, Hirchenhain J, Wen Y, Huang HY et al. Expression of mRNA for vascular endothelial growth factor transmembraneous receptors Flt1 and KDR, and the soluble receptor s-flt in cycling human endometrium. Mol Human Reprod 1999; 5: 452–8.
  • Vuorela P Carpen O, Tulppala M, Halmesmaki E. VEGF, its receptors and the Tie receptors in recurrent miscarriage. Mol Hum Reprod 2000; 6: 276–82.
  • Möller B, Lindblom B, Olovsson M. Localized expression of the angiogenic growth factors vascular endothelial growth factor (VEGF), fibroblast growth factor 2 (FGF-2), epidermal growth factor (EGF), and their receptors innormal human endometrium during the menstrual cycle. Mol Hum Reprod 2001; 1: 65–72.
  • Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V Saksela O et al. Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996; 93: 2576–81.
  • Bellomo D, Headrick JP, Silins GU, Paterson CA, Thomas PS, Gartside M et al. Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res 2000; 86: E29–35.
  • Fong GH, Zhang L, Bryce DM, Peng J. Increased heman-gioblast commitment, not vascular disorganization, is the primary defect in flt-1 knock-out mice. Development 1999; 126: 3015–25.
  • Kaipainen A, Korhonen J, Pajusola K, Aprelikova O, Persico MG, Terman BI et al. The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. J Exp Med 1993; 178: 2077–88.
  • Saaristo A, Partanen TA, Arola J, Jussila L, Hytonen M, Makitie A et al. Vascular endothelial growth factor-C and its receptor VEGFR-3 in the nasal mucosa and in nasopharyngeal tumors. Am J Pathol 2000; 157: 7–14.
  • Olofsson B, Jeltsch M, Eriksson U, Alitalo K. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol 1999; 10: 528–35.
  • Li XF, Charnock-Jones DS, Zhang E, Hiby S, Malik S, Day K et al. Angiogenic growth factor messenger ribonucleic acids in uterine natural killer cells. J Clin Endocrinol Metab 2001; 86: 1823–34.
  • Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994; 269: 26988–95.
  • Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development 1996; 122: 3829–37.
  • Sowter HM, Corps AN, Evans AL. Clark DE, Charnock-Jones DS, Smith SK. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest 1997; 77: 607–14.
  • Eichmann A, Corbel C, Jaffredo T, Breant C, Joukov V, Kumar V et al. Avian VEGF-C: cloning, embryonic expression pattern and stimulation of the differentiation of VEGFR2-expressing endothelial cell precursors. Development 1998; 125: 743–52.
  • Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1: 2–25.
  • Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT et al. Lymphatic endothelium and Kaposis sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 1998; 58: 1599–604.
  • Laitinen M, Ristimaki A, Honkasalo M, Narko K, Paavonen K, Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology 1997; 138: 4748–56.
  • Meduri G, Bausero P, Perrot-Applanat M. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol Reprod 2000; 62: 439–47.
  • Olofsson B, Pajusola K, von Euler G, Chilov D, Alitalo K, Eriksson U. Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 1996; 271: 19310–7.
  • Enholm B, Paavonen K, Ristimaki A, Kumar V Gunji Y, Klefstrom J et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997; 14: 2475–83.
  • Damjanov I, Mildner B, Knowles BB. Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues. Lab Invest 1986; 55: 588–92.
  • Hewett PW, Murray JC. Coexpression of flt-1, flt-4 and KDR in freshly isolated and cultured human endothelial cells. Biochem Biophys Res Commun 1996; 221: 697–702.
  • Marti HH, Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc Natl Acad Sci USA 1998; 95: 15809–14.
  • Sandner P, Wolf K, Bergmaier U, Gess B, Kurtz A. Induction of VEGF and VEGF receptor gene expression by hypoxia: divergent regulation in vivo and in vitro. Kidney Int 1997; 51: 448–53.
  • Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A et al. Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 1997; 272: 25176–83.
  • Lenardo MJ, Baltimore D. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 1989; 58: 227–9.
  • Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 1996; 87: 13–20.
  • Ristimaki A, Narko K, Enholm B, Joukov V, Alitalo K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998; 273: 8413–8.
  • Nayak NR, Critchley HO, Slayden OD, Menrad A, Chwalisz K, Baird DT et al. Progesterone withdrawal up-regulates vascular endothelial growth factor receptor type 2 in the superficial zone stroma of the human and macaque endometrium: potential relevance to menstruation. J Clin Endocrinol Metab 2000; 85: 3442–52.
  • Suzuma I, Mandai M, Takagi H, Suzuma K, Otani A, Oh H et al. 17 Beta-estradiol increases VEGF receptor-2 and promotes DNA synthesis in retinal microvascular endothelial cells. Invest Ophthalmol Vis Sci 1999; 40: 2122–9.
  • Fujimoto J, Hori M, Ichigo S, Tamaya T. Ovarian steroids regulate the expression of basic fibroblast growth factor and its mRNA in fibroblasts derived from uterine endometrium. Ann Clin Biochem 1997; 34: 91–6.
  • Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D et al. Expression of the fmslike tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566–70.
  • Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci USA 1998; 95: 14389–94.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.